Sansure Biotech Inc.
CN¥15.02+CN¥0.03 (+0.2%)
Sansure Biotech Inc.’s quoted price sits in the lower half of its reported 52-week range, 35.95% below the high.
SHZ · 002030.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:04 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Daan Gene Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 36.83% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Daan Gene Co., Ltd.’s forward annual dividend is CN¥0.02 per share, paid annual. The forward yield is 0.29% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Daan Gene Co., Ltd.’s next earnings report is currently expected on Mar 29, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Daan Gene Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Daan Gene Co., Ltd. specializes in the research, development, manufacturing, and commercialization of clinical diagnostic reagents and instruments. The company's extensive product portfolio encompasses advanced solutions such as fluorescence quantitative PCR products, time-resolved series diagnostics, enzyme-linked immunoassay (EIA) kits, various diagnostic instruments, and specialized scientific research services. Beyond product offerings, the company extends its expertise to provide comprehensive medical examination and health management services. These encompass a wide range of offerings, from genetic susceptibility gene testing and tumor marker analysis to crucial cervical cancer screening and general routine physical examinations, alongside other personalized health support. Established in 2001, the company was originally known as Da An Gene Co., Ltd. of Sun Yat-Sen University. It is presently headquartered in Guangzhou, located in the People's Republic of China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:11 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥15.02+CN¥0.03 (+0.2%)
Sansure Biotech Inc.’s quoted price sits in the lower half of its reported 52-week range, 35.95% below the high.
CN¥15.98-CN¥0.10 (-0.62%)
Guangzhou Wondfo Biotech Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 39.22% below the high.
CN¥12.46-CN¥0.04 (-0.32%)
Beijing Strong Biotechnologies, Inc.’s quoted price sits in the lower half of its reported 52-week range, 22.37% below the high.
CN¥66.93-CN¥3.36 (-4.78%)
Beijing Hotgen Biotech Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 68.84% below the high.
CN¥37.84+CN¥0.31 (+0.83%)
Hangzhou Biotest Biotech Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.77% below the high.
CN¥4.45-CN¥0.08 (-1.77%)
Beijing Bohui Innovation Biotechnology Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 48.44% below the high.
CN¥17.08-CN¥0.50 (-2.84%)
Zhejiang Orient Gene Biotech Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 41.08% below the high.
CN¥21.80-CN¥0.93 (-4.09%)
Jiangsu Bioperfectus Technologies Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 65.68% below the high.